AIM: To investigate adjuvant chemotherapy, p53 and carcinoembryonic antigen (CEA) expression and prognosis after D2 gastrectomy for stage II/III gastric adenocarcinoma.
基金Supported by National High Technology Research and Development Program of China(863 Program),China,No.2012AA02A506Science and Technology Department of Guangdong Province,China,No.2012B031800088Medical Scientific Research Foundation of Guangdong Province,China,No.C2011019
文摘AIM: To investigate adjuvant chemotherapy, p53 and carcinoembryonic antigen (CEA) expression and prognosis after D2 gastrectomy for stage II/III gastric adenocarcinoma.
